Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

We are a San Francisco Bay Area-based research stage biopharmaceutical company aiming to discover, develop & commercialize innovative therapeutics for the treatment of rare & age-related diseases. We are developing compounds to modulate molecular pathways that address the underlying causes of disease initiation and progression, such as oxidative, cellular and environmental stress. Our lead compounds are novel & highly selectiv...
We are a San Francisco Bay Area-based research stage biopharmaceutical company aiming to discover, develop & commercialize innovative therapeutics for the treatment of rare & age-related diseases. We are developing compounds to modulate molecular pathways that address the underlying causes of disease initiation and progression, such as oxidative, cellular and environmental stress. Our lead compounds are novel & highly selective therapeutics that potently inhibit the mTORC1 pathway. Genetic mutations, aging result in abnormal activation of mTORC1; normalization of its aberrant activity.

List your booth number for exhibitions, ask us